About Javeri Equity Derivatives Mutual Funds IPO Corporate Info Research Contact Us
Mutual Funds
Mutual Funds
Fund Profile
Scheme Profile
Daily NAV
Historical NAV
Category Returns
Dividend Details
Fund Ranking
MF Activities
All Holdings
What's In / What's Out
MF Trends
MF Tools
  Home   >   MUTUAL FUND  >  MUTUAL FUNDS  > SCHEME PROFILE
SCHEME PROFILE      
AMC : Category : Scheme :
Tata India Pharma & Healthcare Fund(G)-Direct Plan
TypeInvestment In% of NAVNo. of sharesValue (Rs cr)
Domestic EquitiesSUN PHARMACEUTICAL INDUSTRIES LTD11.7874804300139.5219
Domestic EquitiesAUROBINDO PHARMA LTD7.265174100085.9931
Domestic EquitiesCIPLA LTD5.970349000070.6678
Domestic EquitiesAPOLLO HOSPITALS ENTERPRISE LTD5.659810125566.9923
Domestic EquitiesLUPIN LTD5.195430324061.4956
Domestic EquitiesDIVI LABORATORIES LTD5.121610496560.6220
Domestic EquitiesFORTIS HEALTHCARE LTD5.045185510059.7159
Domestic EquitiesASTER DM HEALTHCARE LTD3.909195699146.2705
Domestic EquitiesDR REDDYS LABORATORIES LTD3.495036155541.3691
Domestic EquitiesWOCKHARDT LTD3.307827487139.1526
Domestic EquitiesALKEM LABORATORIES LTD3.10357524936.7343
Domestic EquitiesHEALTHCARE GLOBAL ENTERPRISES LTD3.050866612136.1104
Domestic EquitiesLAURUS LABS LTD2.617050500030.9767
Domestic EquitiesAJANTA PHARMA LTD2.09949473724.8495
Domestic EquitiesTORRENT PHARMACEUTICALS LTD1.93417092122.8929
Domestic EquitiesIPCA LABORATORIES LTD1.807514245221.3949
Domestic EquitiesMETROPOLIS HEALTHCARE LTD1.799913617321.3049
Domestic EquitiesKRISHNA INSTITUTE OF MEDICAL SCIENCES LTD1.769432745220.9438
Domestic EquitiesDR. AGARWALS HEALTH CARE LTD1.714645518720.2945
Domestic EquitiesMEDI ASSIST HEALTHCARE SERVICES LTD1.609741867019.0537
Domestic EquitiesFDC LTD1.568647128318.5662
Domestic EquitiesDR. LAL PATH LABS LTD1.47117024617.4126
Domestic EquitiesJUPITER LIFE LINE HOSPITALS LTD1.435010638916.9855
Domestic EquitiesZYDUS LIFESCIENCES LTD1.402518728716.6011
Domestic EquitiesINDOCO REMEDIES LTD1.312366699215.5336
Domestic EquitiesORCHID PHARMA LTD1.081916500012.8057
Domestic EquitiesAMI ORGANICS LTD1.03105000012.2040
Domestic EquitiesAKUMS DRUGS AND PHARMACEUTICALS LTD1.028825735212.1779
Domestic EquitiesCOROMANDEL INTERNATIONAL LTD1.00476000011.8926
Domestic EquitiesSANOFI INDIA LTD0.92701916410.9722
Domestic EquitiesMANKIND PHARMA LTD0.84904144610.0496
Domestic EquitiesSANOFI CONSUMER HEALTHCARE INDIA LTD0.7815191649.2500
Domestic EquitiesMEDPLUS HEALTH SERVICES LTD0.76281188089.0294
Domestic EquitiesPROCTER & GAMBLE HEALTH LTD0.6957160008.2344
Domestic EquitiesSYNGENE INTERNATIONAL LTD0.65681070467.7737
Domestic EquitiesGLAXOSMITHKLINE PHARMACEUTICALS LTD0.5983245887.0822
Domestic EquitiesINVENTURUS KNOWLEDGE SOLUTIONS LTD0.5392417426.3821
Domestic EquitiesDEEPAK NITRITE LTD0.3001179093.5524
Domestic EquitiesLAXMI DENTAL LTD0.0540143570.6391
Total 95.7629 1133.5007
Cash & Cash Equivalents and Net AssetsCASH / NET CURRENT ASSET4.0300 47.7007
Cash & Cash Equivalents and Net AssetsA) REPO0.2071 2.4518
Total 4.2371 50.1525
 
Back Back TopTop
Disclaimer | Privacy Policy | Grievance | FAQ | Sitemap | Client Registration | Useful Links| Anti Money Laundering | Inactive Client Policy | Scores
Vernacular Kyc | Advisory For Investors | Investor Adviser | Filing complaints on SCORES - Easy & quick | Policy on PMLA
Publishing of investor charter information | Annexure A – Investor charter of brokers |
Annexure A – Investor charter of DP | Annexure B –Linked content for information to charter for DP | Annexure B & C (investor complaint data) broker & DP
Investor Charter & Complaints | Advisory-KYC Compliance | E-Voting NSE | E-Voting BSE | Details of Client Bank Accounts | Risk Disclosure | NSE FO Risk disclosure
SEBI Regn. No.: INB010997431 (BSE), INB230997430 (NSE)
Copyright 2008 Javeri Fiscal Services Ltd.
Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.
CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Source: Click Here.